Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer

Condition:   Biliary Tract Neoplasms
Interventions:   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Ipilimumab;   Drug: Nivolumab
Sponsor:   University of Michigan Cancer Center
Not yet recruiting - verified March 2017

http://ift.tt/2p1sR86